Dr. Agajanian is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
11480 Brookshire Ave
Ste 309
Downey, CA 90241Phone+1 562-869-1201Fax+1 562-869-1281
Education & Training
- Olive View/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 2001 - 2004
- Olive View/UCLA Medical CenterResidency, Internal Medicine, 1998 - 2001
- University of California, Irvine, School of MedicineClass of 1998
Certifications & Licensure
- AZ State Medical License 2016 - 2026
- MT State Medical License 2022 - 2026
- CA State Medical License 2000 - 2025
- NV State Medical License 2018 - 2025
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Top MD Consumers Checkbook
Clinical Trials
- Glufosfamide Versus 5-FU in Second Line Metastatic Pancreatic Cancer Start of enrollment: 2014 Apr 01
- Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab in Adults With Previously Untreated Chronic Lymphocytic Leukemia Start of enrollment: 2014 Feb 05
- Study of Rituximab and Bendamustine With or Without Brentuximab Vedotin for CD30 Positive Diffuse Large B-cell Lymphoma Start of enrollment: 2015 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 85 citationsCHAMPION-1: a phase 1/2 study of once-weekly carfilzomib and dexamethasone for relapsed or refractory multiple myeloma.James R. Berenson, Alan Cartmell, Alberto Bessudo, Roger M. Lyons, Wael A. Harb
Blood. 2016-06-30 - 20 citationsAPF530 (granisetron injection extended-release) in a three-drug regimen for delayed CINV in highly emetogenic chemotherapyIan D. Schnadig, Richy Agajanian, Christopher Dakhil, Nashat Y. Gabrail, Robert E. Smith
Future Oncology. 2016-03-21 - 15 citationsFostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open-label study.David J Kuter, Kerry A Rogers, Michael A Boxer, Michael Choi, Richy Agajanian
American Journal of Hematology. 2022-06-01
Press Mentions
- Value-Based Model Improves End-of-Life Cancer CareDecember 23rd, 2019
- End of Life Cancer Care: Lay Health Workers Improved Quality of Life and Reduced CostsSeptember 17th, 2019
- Study Demonstrates Significantly Better Quality Cancer Care and Lower Costs with a Value-Based Care Model Implemented by the Oncology Institute and CareMore HealthSeptember 7th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: